Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60083 |
MMP-12 Inhibitor
MMP12,MMP408 |
MMP | Proteases/Proteasome |
MMP-12 Inhibitor 是一种选择性的 MMP-12 抑制剂,对人、小鼠、大鼠和绵羊 MMP-12 的 IC50 分别为 2、160、320 和 22.3 nM。 | |||
T27603 |
INCB3619
INCB-3619,INCB 3619 |
Immunology/Inflammation related | Immunology/Inflammation |
INCB3619 是一种具有选择性和高效性的 ADAM 的抑制剂,具有抗肿瘤作用,抑制 ADAM10、ADAM17、MMP12 和 MMP15。 | |||
T10474 | BAY-7598 | Others | Others |
BAY-7598 is a potent, selective, and orally bioavailable MMP12 inhibitor (IC50s: 0.085, 0.67, and 1.1 nM for human/murine/rat MMP12). | |||
T26720 |
AZD-6605
AZ11920155,AZ-11920155,AZD6605 |
||
AZD6605 is a potent, reversible inhibitor of, MMP2, MMP9, MMP12 and MMP13. | |||
T78181 |
MMP-7-IN-2
|
MMP; Others | Others; Proteases/Proteasome |
MMP-7-IN-2 可作为一种具有选择性和有效性的 MMP7 抑制剂,可用于研究炎症反应和与血管相关的疾病。 | |||
T12414 |
PF-00356231 hydrochloride
|
MMP | Proteases/Proteasome |
PF-00356231 hydrochloride 是基质金属蛋白酶 MMP-12 的抑制剂,IC50 为 1.4 μM。 | |||
T27654 |
JG26
JG 26,JG-26 |
MMP; Immunology/Inflammation related | Immunology/Inflammation; Proteases/Proteasome |
JG26 是一种强效的 ADAM17 抑制剂,对 ADAM8、ADAM17、ADAM10 和 MMP-12 均有抑制作用,其 IC50 值分别为 12 nM、1.9 nM、150 nM 和 9.4 nM,可用于研究机体免疫系统。 | |||
T15015 |
CTS-1027
RS 130830,Ro 1130830 |
Others | Others |
CTS-1027 is a small molecule inhibitor of MMPs (IC50s: 0.3 nM, 0.5 nM for MMP2, MMP13). It has > 1,000 fold selectivity over MMP1. | |||
T13249 |
UK-370106
|
MMP | Proteases/Proteasome |
UK-370106 is a potent and highly selective inhibitor of MMP-3 with IC50 of 23 nM and MMP-12 with IC50 of 42 nM, and potently inhibits cleavage of [3H]-fibronectin by MMP-3 (IC50: 320 nM). | |||
T31063 |
CP-544439
UNII-516DO4KL5R |
||
CP-544439 is an inhibitor of matrix metalloproteinase-13, which has an effect on adipose tissue development. | |||
T36492 | CMC2.24 | ||
CMC2.24 (TRB-N0224) is an orally active tricarbonylmethane agent that demonstrates effectiveness in inhibiting Ras activation and the downstream effector ERK1/2 pathway, thus effectively combating pancreatic tumor formation in mice. Additionally, CMC2.24 exerts potent inhibitory effects on zinc-dependent MMPs, with IC50s ranging from 2.0-69 μM. Furthermore, CMC2.24 aids in alleviating the progression of osteoarthritis by restoring cartilage homeostasis and inhibiting chondrocyte apoptosis throug... |